Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Consolidated Net Income (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Consolidated Net Income for 6 consecutive years, with -$12.5 million as the latest value for Q4 2025.

  • Quarterly Consolidated Net Income fell 29.29% to -$12.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$47.1 million through Dec 2025, changed 0.5% year-over-year, with the annual reading at -$47.1 million for FY2025, 0.5% changed from the prior year.
  • Consolidated Net Income hit -$12.5 million in Q4 2025 for Rapid Micro Biosystems, down from -$11.5 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of -$9.7 million in Q4 2024 to a low of -$25.0 million in Q3 2021.
  • Historically, Consolidated Net Income has averaged -$14.0 million across 5 years, with a median of -$13.2 million in 2022.
  • Biggest five-year swings in Consolidated Net Income: tumbled 195.18% in 2021 and later soared 34.61% in 2022.
  • Year by year, Consolidated Net Income stood at -$14.6 million in 2021, then fell by 12.61% to -$16.4 million in 2022, then surged by 32.07% to -$11.2 million in 2023, then rose by 13.48% to -$9.7 million in 2024, then fell by 29.29% to -$12.5 million in 2025.
  • Business Quant data shows Consolidated Net Income for RPID at -$12.5 million in Q4 2025, -$11.5 million in Q3 2025, and -$11.9 million in Q2 2025.